India and Brazil have exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the regulation of pharmaceutical and medical products.
According to a statement by the Ministry of Health and Family Welfare, the MoU was signed between India’s Central Drugs Standard Control Organisation (CDSCO) and the Brazilian Health Regulatory Agency (ANVISA). The agreement aims to promote convergence in regulatory practices, enhance mutual understanding of regulatory systems, and facilitate coordinated oversight of medical products.
The MoU was exchanged in New Delhi by Indian Ambassador to Brazil Dinesh Bhatia and ANVISA Director-President Leandro Safatle. The exchange took place in the presence of Narendra Modi and Luiz Inácio Lula da Silva.
The Ministry stated that the agreement reflects the shared commitment of both nations to ensuring the availability of safe, effective, and quality-assured medicines and medical products for their populations.
The MoU is expected to deepen India–Brazil cooperation in the health sector and strengthen global regulatory collaboration in pharmaceuticals.
